Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle DeVeaux

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Statistics and Its Interface|January 19, 2019
Clinical Trial Design Using A Stopped Negative Binomial DistributionMichelle DeVeaux, Michael J Kane, Daniel Zelterman
Pharmaceutical Statistics|September 12, 2019
A two-stage phase II clinical trial design with nested criteria for early stopping and efficacyMichelle DeVeaux, Michael Kane, Wei Wei, et al.
Annals of Hematology|November 11, 2018
Systematic review and meta-analysis of the effect of iron chelation therapy on overall survival and disease progression in patients with lower-risk myelodysplastic syndromesAmer M Zeidan, Smith Giri, Michelle DeVeaux, et al.
Nucleic Acids Research|November 22, 2017
DNA polymerase beta participates in DNA End-joiningSreerupa Ray, Gregory Breuer, Michelle DeVeaux, et al.
American Journal of Hematology|April 11, 2018
The effect of iron chelation therapy on overall survival in sickle cell disease and β-thalassemia: A systematic reviewSamir K Ballas, Amer M Zeidan, Vu H Duong, et al.
Cannabis and Cannabinoid Research|September 14, 2020
Daily Cannabis Users with Sickle Cell Disease Show Fewer Admissions than Others with Similar Pain ComplaintsSusanna A Curtis, Amanda M Brandow, Michelle DeVeaux, et al.
Molecular Cancer Research : MCR|January 12, 2017
DNA Polymerase Beta Germline Variant Confers Cellular Response to Cisplatin TherapyAntonia A Nemec, Laura Abriola, Jane S Merkel, et al.
Blood Cancer Journal|June 13, 2018
Counseling patients with higher-risk MDS regarding survival with azacitidine therapy: are we using realistic estimates?Amer M Zeidan, Maximilian Stahl, Michelle DeVeaux, et al.
Clinical and Translational Science|August 26, 2021
REGN1908-1909 monoclonal antibodies block Fel d 1 in cat allergic subjects: Translational pharmacokinetics and pharmacodynamicsMohamed A Kamal, Robert Dingman, Claire Q Wang, et al.
Annals of Hematology|July 21, 2018
Long-term follow-up of a single institution pilot study of sirolimus, tacrolimus, and short course methotrexate for graft versus host disease prophylaxis in mismatched unrelated donor allogeneic stem cell transplantationTae Kon Kim, Michelle DeVeaux, Maximilian Stahl, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Statistics and Its Interface|January 19, 2019
Clinical Trial Design Using A Stopped Negative Binomial DistributionMichelle DeVeaux, Michael J Kane, Daniel Zelterman
Pharmaceutical Statistics|September 12, 2019
A two-stage phase II clinical trial design with nested criteria for early stopping and efficacyMichelle DeVeaux, Michael Kane, Wei Wei, et al.
Annals of Hematology|November 11, 2018
Systematic review and meta-analysis of the effect of iron chelation therapy on overall survival and disease progression in patients with lower-risk myelodysplastic syndromesAmer M Zeidan, Smith Giri, Michelle DeVeaux, et al.
Nucleic Acids Research|November 22, 2017
DNA polymerase beta participates in DNA End-joiningSreerupa Ray, Gregory Breuer, Michelle DeVeaux, et al.
American Journal of Hematology|April 11, 2018
The effect of iron chelation therapy on overall survival in sickle cell disease and β-thalassemia: A systematic reviewSamir K Ballas, Amer M Zeidan, Vu H Duong, et al.
Cannabis and Cannabinoid Research|September 14, 2020
Daily Cannabis Users with Sickle Cell Disease Show Fewer Admissions than Others with Similar Pain ComplaintsSusanna A Curtis, Amanda M Brandow, Michelle DeVeaux, et al.
Molecular Cancer Research : MCR|January 12, 2017
DNA Polymerase Beta Germline Variant Confers Cellular Response to Cisplatin TherapyAntonia A Nemec, Laura Abriola, Jane S Merkel, et al.
Blood Cancer Journal|June 13, 2018
Counseling patients with higher-risk MDS regarding survival with azacitidine therapy: are we using realistic estimates?Amer M Zeidan, Maximilian Stahl, Michelle DeVeaux, et al.
Clinical and Translational Science|August 26, 2021
REGN1908-1909 monoclonal antibodies block Fel d 1 in cat allergic subjects: Translational pharmacokinetics and pharmacodynamicsMohamed A Kamal, Robert Dingman, Claire Q Wang, et al.
Annals of Hematology|July 21, 2018
Long-term follow-up of a single institution pilot study of sirolimus, tacrolimus, and short course methotrexate for graft versus host disease prophylaxis in mismatched unrelated donor allogeneic stem cell transplantationTae Kon Kim, Michelle DeVeaux, Maximilian Stahl, et al.
Pageof 3